EP1494709A4 - Compositions and methods for the diagnosis and treatment of tumor - Google Patents

Compositions and methods for the diagnosis and treatment of tumor

Info

Publication number
EP1494709A4
EP1494709A4 EP02723890A EP02723890A EP1494709A4 EP 1494709 A4 EP1494709 A4 EP 1494709A4 EP 02723890 A EP02723890 A EP 02723890A EP 02723890 A EP02723890 A EP 02723890A EP 1494709 A4 EP1494709 A4 EP 1494709A4
Authority
EP
European Patent Office
Prior art keywords
tumor
diagnosis
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02723890A
Other languages
German (de)
French (fr)
Other versions
EP1494709A2 (en
Inventor
Audrey Goddard
Austin L Gurney
Paul Polakis
Victoria Smith
William I Wood
Thomas D Wu
Zemin Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of EP1494709A2 publication Critical patent/EP1494709A2/en
Publication of EP1494709A4 publication Critical patent/EP1494709A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP02723890A 2002-04-17 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor Withdrawn EP1494709A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/012206 WO2003088898A2 (en) 2002-04-17 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor

Publications (2)

Publication Number Publication Date
EP1494709A2 EP1494709A2 (en) 2005-01-12
EP1494709A4 true EP1494709A4 (en) 2006-06-28

Family

ID=29247990

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02723890A Withdrawn EP1494709A4 (en) 2002-04-17 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor

Country Status (7)

Country Link
EP (1) EP1494709A4 (en)
JP (1) JP2005523311A (en)
KR (1) KR20040111525A (en)
AU (1) AU2002254651A1 (en)
CA (1) CA2481085A1 (en)
MX (1) MXPA04010091A (en)
WO (1) WO2003088898A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057194A2 (en) * 2000-02-03 2001-08-09 Corvas International, Inc. Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
WO2001068848A2 (en) * 2000-03-01 2001-09-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001083781A2 (en) * 2000-04-28 2001-11-08 Millennium Pharmaceuticals, Inc. 14094, a novel human trypsin family member and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082540A1 (en) * 1997-09-17 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6291663B1 (en) * 1999-03-03 2001-09-18 Board Of Trustees Of The University Of Arkansas TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057194A2 (en) * 2000-02-03 2001-08-09 Corvas International, Inc. Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
WO2001068848A2 (en) * 2000-03-01 2001-09-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001083781A2 (en) * 2000-04-28 2001-11-08 Millennium Pharmaceuticals, Inc. 14094, a novel human trypsin family member and uses thereof

Also Published As

Publication number Publication date
JP2005523311A (en) 2005-08-04
MXPA04010091A (en) 2004-12-13
WO2003088898A2 (en) 2003-10-30
AU2002254651A1 (en) 2003-11-03
EP1494709A2 (en) 2005-01-12
KR20040111525A (en) 2004-12-31
WO2003088898A3 (en) 2004-09-16
CA2481085A1 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
EP1571968A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1589933A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1572091A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1553912A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1578996A4 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004030615A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1571968A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004016225A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1575571A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1572091A3 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003302892A8 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
EP1575480A4 (en) Compositions and methods for the treatment of immune related diseases
EP1578367A4 (en) Compositions and methods for the treatment of immune related diseases
EP1572116A4 (en) Compositions and methods for the treatment of immune related diseases
EP1576137A4 (en) Compositions and methods for the treatment of immune related diseases
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
IL162201A0 (en) New methods for diagnosis and treatment of tumours
EP1551990A4 (en) Diagnosis and treatment of chemoresistant tumors
AU2003300368A8 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
EP1516049A4 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003290605A8 (en) Compositions and methods for the diagnosis and treatment of sepsis
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
ZA200510282B (en) Compositions and methods for the diagnosis and treatment of tumor
EP1446013A4 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041026

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ZHANG, ZEMIN

Inventor name: WU, THOMAS, D.

Inventor name: WOOD, WILLIAM, I.

Inventor name: SMITH, VICTORIA

Inventor name: POLAKIS, PAUL

Inventor name: GURNEY, AUSTIN, L.

Inventor name: GODDARD, AUDREY

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ZHANG, ZEMIN

Inventor name: WU, THOMAS, D.

Inventor name: WOOD, WILLIAM, I.

Inventor name: SMITH, VICTORIA

Inventor name: POLAKIS, PAUL

Inventor name: GURNEY, AUSTIN, L.

Inventor name: GODDARD, AUDREY

A4 Supplementary search report drawn up and despatched

Effective date: 20060526

17Q First examination report despatched

Effective date: 20070705

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080116